C4 Therapeutics (CCCC) EBIT (2019 - 2026)
C4 Therapeutics (CCCC) recorded quarterly EBIT of -$27.8 million in Q1 2026, down 20.05% quarter-over-quarter from -$23.1 million in Q4 2025, and up 4.73% on a YoY basis from -$26.5 million in Q1 2025.
C4 Therapeutics (CCCC) EBIT (2019 - 2026) Analysis & Trends
C4 Therapeutics' EBIT history runs 8 years deep, the most recent figure standing at -$27.8 million for Q1 2026.
- In Q1 2026, EBIT rose 4.73% year-over-year to -$27.8 million; the TTM figure through Mar 2026 stood at -$113.8 million (up 2.33% YoY), while the FY2025 annual figure was -$115.2 million, up 3.67% from the prior year.
- EBIT was -$27.8 million for Q1 2026 at C4 Therapeutics, down from -$23.1 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$21.4 million in Q2 2024 to a low of -$38.3 million in Q4 2022.
- Historically, EBIT has averaged -$31.2 million across 5 years, with a median of -$31.4 million in 2022.
- The sharpest annual moves came in 2022 and 2024: EBIT plunged 151.02% in 2022, then surged 42.92% in 2024.
- A 5-year view of EBIT shows it stood at -$38.3 million in 2022, then advanced by 2.26% to -$37.4 million in 2023, then decreased by 0.75% to -$37.7 million in 2024, then soared by 38.62% to -$23.1 million in 2025, then fell by 20.05% to -$27.8 million in 2026.
- The last three EBIT figures came in at -$27.8 million (Q1 2026), -$23.1 million (Q4 2025), and -$34.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | C4 Therapeutics | 492.32 Mn | 256.65 Mn | - | -27.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.79 Mn |
| Dec 31, 2025 | -23.15 Mn |
| Sep 30, 2025 | -34.41 Mn |
| Jun 30, 2025 | -28.50 Mn |
| Mar 31, 2025 | -29.16 Mn |
| Dec 31, 2024 | -37.71 Mn |
| Sep 30, 2024 | -28.24 Mn |
| Jun 30, 2024 | -21.44 Mn |
| Mar 31, 2024 | -32.22 Mn |
| Dec 31, 2023 | -37.43 Mn |
| Sep 30, 2023 | -27.81 Mn |
| Jun 30, 2023 | -37.57 Mn |
| Mar 31, 2023 | -36.23 Mn |
| Dec 31, 2022 | -38.29 Mn |
| Sep 30, 2022 | -32.49 Mn |
| Jun 30, 2022 | -27.38 Mn |
| Mar 31, 2022 | -31.37 Mn |
| Dec 31, 2021 | -15.26 Mn |
| Sep 30, 2021 | -24.25 Mn |
| Jun 30, 2021 | -22.12 Mn |